Global Clot Management Devices
Market Regional Analysis
North America is expected to hold
a dominant position in the global Clot
Management Devices Market over the forecast period, owing to frequent
research and development activities in the region.
For instance, in April 2019,
Tufts Medical Center in Boston and Eskenazi Health, a partner with the Indiana
University School of Medicine, are developing a Mobile Active Compression (MAC)
calf device for prevention of deep vein thrombosis. MAC is light-weight and
portable device, which can be worn around limbs, as limbs have higher risk of
deep vein thrombosis. Such innovations associated with clot management devices
are expected to accelerate the global clot management devices market growth.
Blood clot is usually a response
to the injury so as to prevent infection and minimize the blood flow. Embolus
is a part of blood-clotting, which separates from the site of thrombus and
circulate through bloodstream into the body. It can obstruct the function of
blood vessels and thus leading to harmful effects in the body. High
cholesterol, heavy weight of body, diabetes, cancer, and sedentary lifestyle
can be a cause for clotting of blood in the body. These blood clots can be
treated by medications such as anti-coagulants, compression stockings, surgery,
stents, and vena cava filter. These treatments prevent from formation of more
blood clots in the body.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2650
Global Clot Management Devices
Market Drivers
Approval and launch of the novel
clot management devices are expected to boost the global clot management
devices market. For instance, in May 2019, the U.S. Food and Drug
Administration (FDA) approved Bashir Endovascular Catheter (BEC) and Bashir N-X
endovascular catheter (BEC N-X) developed by a scientist from Temple University
Hospital in Philadelphia, Pennsylvania and is being commercialized by
Thrombolex, Inc. BEC received approval for its controlled infusion of fluids
(thrombolytics) in peripheral vasculature and BEC N-X is being used for
controlled infusion of fluids into pulmonary and peripheral vasculature.
Furthermore, key players are also
trying to expand the indications of its already approved products. For
instance, in February 2018, the U.S. FDA expanded indications for Trevo clot
retriever, a device designed by Stryker Corporations. Trevo Retriever is the
first thrombectomy device to receive approval for expansion by 18 hours of
treatment time for acute ischemic stroke. Originally Trevo clot retriever had
been approved in 2012. Such frequent approvals by the U.S. FDA is expected to
drive the global clot management device market growth.
Furthermore, activities such as
collaborations, partnerships, merger, and acquisitions of the manufacturers are
expected to drive the global clot management devices market growth. For
instance, in September 2018, LeMaitre Vascular Corporation acquired vascular
clot management business of Applied Medical Resources Corporation. The parties
had undergone an agreement of transitional services, where Applied Medical
Resources Corporation was supposed to manufacture its clot management product
line for LeMaitre Vascular Corporation. This factor is expected to have a
positive influence on the global clot management devices market growth over the
forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/clot-management-devices-market-2650
Global Clot Management Devices
Market Restraints
High cost of clot management
devices is expected to hamper the global clot management devices market growth
over the forecast period. For instance, according to the data published by
National Center for Biotechnology Information (NCBI) in 2016, the cost of 5MAX
ACE catheter, used for the extraction of clots in ischemic stroke was around
US$ 4,916. Hence, high cost may lead to lesser adoption of devices and thereby,
hindering the global clot management devices market growth.
Global Clot Management Devices
Market Key Players
Some of the major players
operating in the global clot management devices market include Edward
Lifesciences Corporation, Straub Medical AG, Boston Scientific Corporation,
Medtronic, Inc., Volcano Corporation, LeMaitre Vascular, Inc., Teleflex Inc.,
Argon Medical, Stryker Corporation, and Angiodynamics.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2650
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment